Promoter holding
64.27%
PM
Poly Medicure Limited - Due diligence report
A 360° intelligence report on Polymedicure: trust score, financial health, credit view, compliance, directors, growth and distress signals -…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Polymedicure — 360° Intelligence Report
Generated from MCA filings & public records69/100
Trust Score
Moderate
Polymedicure is assessed as Moderate with a Trust Score of 69/100. Polymedicure is an active public limited indian non-government company incorporated in 1995, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 20 Jul 2026 from the latest processed filings. Poly Medicure Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
69/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
42/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
35/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 5 open (479.50 cr) · 5 satisfied (140.20 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Sbicap Trustee Company Limited | 1 | 48.0 cr |
| Others | 2 | 48.0 cr |
| The Hongkong And Shanghai Banking Corporation Limited | 3 | 48.0 cr |
| Hdfc Bank Limited | 2 | 48.0 cr |
| Citi Bank N.A. | 2 | 48.0 cr |
Compliance Score: 42/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE, DSE.
- Litigation present in 3 court forum(s).
- Delayed payments to MSME suppliers disclosed (8 disclosure(s)).
- 6 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 35/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VISHAL GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALESSANDRO BALBONI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMBRISH MITHAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NARESH VIJAYVERGIYA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VIMAL BHANDARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SONAL MATTOO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANDEEP BHARGAVA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMIT KHOSLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VISHAL BAID | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HIMANSHU BAID | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAVI PRAKASH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AVINASH CHANDRA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JUGAL KISHORE BAID | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DEVENDRA RAJ MEHTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RISHI BAID | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Pankaj Kumar Gupta | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 16 directors on the board.
- AMBRISH MITHAL has DIN status "Deactivated".
- 7 director exits in 3 years - high churn.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
8 allotment(s) · 5 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Oly Medicure (laiyang) Co. Ltdchina | Subsidiary Company | 74.00% |
| Plan 1 Health S.r.l., Italy | Subsidiary Company | 74.00% |
| Plan1 Health India Pvt Ltd. | Subsidiary Company | 74.00% |
| Poly Health Medical Inc., Usa | Subsidiary Company | 74.00% |
| Poly Medicure B.v.,netherlands | Subsidiary Company | 74.00% |
| Ultra For Medical Products Company (ultramed) | Associate Company | 74.00% |
Key managerial personnel: NARESH VIJAYVERGIYA (CFO) · HIMANSHU BAID (Managing Director) · RISHI BAID (Whole-time director) · Pankaj Kumar Gupta (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
EPFO headcount growing - hiring signal.
Operating for 31+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
6 director exits within 2 years.
Compliance score is weak (42/100).
5 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 6.28 Lakh.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment82/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 5 open charge(s) of 479.50 cr already registered.
- Compliance gaps should be priced into terms.
Investor view88/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 6 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events25 Sep 2025
Last AGM held
Annual general meeting
24 Sep 2025
Director ceased
Pankaj Kumar Gupta
08 Aug 2025
Director appointed
Pankaj Kumar Gupta (Whole-time director)
04 Aug 2025
Director ceased
VISHAL BAID
06 May 2025
Director appointed
VISHAL BAID (Director)
18 Apr 2025
Charge created
Hdfc Bank Limited - 30.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
24 Jan 2025
Director ceased
VISHAL GUPTA
28 Oct 2024
Director appointed
VISHAL GUPTA (Director)
18 Oct 2024
Charge satisfied
Others
26 Sep 2024
Director ceased
SANDEEP BHARGAVA
25 Sep 2024
Director ceased
VIMAL BHANDARI
Director ceased
DEVENDRA RAJ MEHTA
22 Jul 2024
Director appointed
VIMAL BHANDARI (Director)
17 Jul 2024
Director ceased
PRAKASH CHAND SURANA
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
16 active director(s) / partner(s); review board churn before relying on management continuity.
6 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A from Crisil.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 8 security allotment(s) - amounts available in the full report.
32 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Jk Fenner | U24231TN1992PLC062306 | Madurai, Tamil Nadu, India |
| Bharathicement | U26942TG1999PTC031682 | Hyderabad, Telangana, India |
| Polyplex Corporation Limited | L25209UR1984PLC011596 | Uttranchal, Uttarakhand, India |
| Paragon | U00311KA1988PTC009613 | Bangalore - 562 123,Karnataka, Karnataka, India |
| Kingfa | L25209TN1983PLC010438 | Madras, Tamil Nadu, India |
| Bmw Ventures Limited | L25111BR1994PLC006131 | Patna, Bihar, India |
| Garware Poly | L10889MH1957PLC010889 | Chhatrapati Sambhajinagar, Maharashtra, India |
| Walkaroo | U19200TZ2011PTC029228 | Coimbatore, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Polymedicure before audits and certifications: compliance score 42/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Polymedicure: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Polymedicure - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 69/100, distress signals and MSME payment-delay disclosures - know whether Polymedicure pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Polymedicure - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Polymedicure an active company?
Polymedicure has MCA status “Active” with a compliance score of 42/100 (Caution Indicated).
Is Polymedicure financially healthy?
Polymedicure has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Polymedicure?
Its overall Trust Score is 69/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Polymedicure?
Promoters hold a majority stake - exact percentages are in the full report. 16 active director(s) are on record.
Does Polymedicure have loans or charges against its assets?
5 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Polymedicure up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 42/100 (Caution Indicated).
Is it risky to lend to Polymedicure?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
